Floatz logo

SODIUM STIBOGLUCONATE ANHYDROUS

Myelodysplastic Syndromes

First Affiliated Hospital of Jinan UniversitySmall moleculePhase 2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
65/ 100

Competitive context

315 Active assets in the Myelodysplastic Syndromes cohort.

Asset / SponsorPhaseRating
Fludarabine
Sawa Ito, MD
Phase 4BB
Anti-Thymoglobulin, Rabbit
Peking University First Hospital
Phase 2/3BB
Cytosin-Arabinosid
The First Affiliated Hospital of Soochow University
Phase 4BB
FILGRASTIM
City of Hope Medical Center
Phase 4BB
Daunorubicin
OHSU Knight Cancer Institute
Phase 3BB

View all 50 →

Same molecule, other indications

SODIUM STIBOGLUCONATE ANHYDROUS is also rated in:

myeloid neoplasmDormant
CCC
Indicative ·
53 / 100
View asset →
Sodium StibogluconateDormant
CCC
Indicative ·
53 / 100
View asset →
metastatic melanomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →